ExodusPoint Capital Management’s Lifestance Health LFST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-310,541
Closed -$3.33M – 1952
2026
Q2
$3.33M Sell
310,541
-178,922
-37% -$1.38M 0.02% 622
2026
Q1
$3.12M Buy
+489,463
New +$3.41M 0.02% 605
2025
Q4
– Sell
-561,953
Closed -$3.09M – 1819
2025
Q3
$3.09M Buy
+561,953
New +$2.75M 0.03% 577
2025
Q2
– Sell
-28,472
Closed -$190K – 1751
2025
Q1
$190K Buy
+28,472
New +$216K ﹤0.01% 1306
2024
Q2
– Sell
-158,823
Closed -$980K – 1773
2024
Q1
$980K Buy
+158,823
New +$1.07M 0.01% 952
2023
Q4
– Sell
-121,013
Closed -$831K – 1791
2023
Q3
$831K Buy
+121,013
New +$981K 0.01% 1023

Other funds holding LFST

ExodusPoint Capital Management's LFST Position: Q3 2026 in Review

ExodusPoint Capital Management sold out of Lifestance Health (LFST) in Q3 2026, closing a stake of 310,541 shares — an estimated $3.33M sold.

ExodusPoint Capital Management first reported a position in LFST in Q3 2023 and held it in 6 quarters. The position peaked at $3.33M in Q2 2026. 324 funds tracked by Wall St. Rank hold LFST as of Q3 2026.

  • ExodusPoint Capital Management reported no remaining Lifestance Health position as of Q3 2026 after selling out during the quarter.
  • ExodusPoint Capital Management sold 310,541 Lifestance Health shares in Q3 2026, an estimated $3.33M.
  • ExodusPoint Capital Management first reported a position in Lifestance Health in Q3 2023 and held it in 6 quarters.
  • ExodusPoint Capital Management's Lifestance Health position peaked at $3.33M in Q2 2026.
  • 324 funds tracked by Wall St. Rank held Lifestance Health as of Q3 2026.

Based on ExodusPoint Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.